Mirtazapine found ineffective in reducing breathlessness in respiratory disease patients in phase 3 trial Dr. Kamal Kant Kohli16 Sept 2024 3:00 AM ISTA new study from King's College London shows that off-label prescriptions of a common antidepressant doesn't help breathlessness in patients with...
GSK announces positive results from phase III trial of Nucala in COPD Ruchika Sharma8 Sept 2024 1:30 PM ISTLondon: GSK plc has announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala (mepolizumab) a...
Tiotropium Influences Eye Measurements in COPD Patients Without Causing Glaucoma: Study Medha Baranwal30 Aug 2024 9:00 PM ISTTurkey: A recent study published in BMC Pulmonary Medicine has shed new light on the effects of Tiotropium, a commonly prescribed medication for...
Frequent and Severe COPD Exacerbations Linked to Higher Risks of Myocardial Infarction and Pulmonary Embolism: Study Medha Baranwal29 Aug 2024 8:00 PM ISTSweden: A recent study into chronic obstructive pulmonary disease (COPD) has unveiled a troubling correlation between the frequency and severity of...
Inhaler misuse tied to mismanagement of COPD symptoms, increased exacerbations, suggests study Dr. Kamal Kant Kohli23 Aug 2024 8:00 PM ISTInhaler misuse leading to inadequate medication delivery impacts a person's ability to manage symptoms of chronic obstructive pulmonary disease...
CDSCO Panel Approves AstraZeneca's protocol amendment proposal for COPD drug Tozorakimab Dr. Divya Colin19 Aug 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Dupixent approved in EU as targeted therapy for COPD: Sanofi, Regeneron Pharma Ruchika Sharma3 July 2024 2:00 PM ISTParis: Sanofi and Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has approved Dupixent (dupilumab) as...
FDA approves new inhaled nonsteroidal nebulizer therapy ensifentrine for COPD Dr. Kamal Kant Kohli27 Jun 2024 8:00 PM ISTThe US Food and Drug Administration (FDA) has approved ensifentrine an inhaled nonsteroidal nebulizer therapy for the treatment of patients with...
Conduct BE study: CDSCO Panel Tells Sun Pharma Labs on COPD drug Umeclidinium powder for inhalation Dr. Divya Colin31 May 2024 6:00 PM ISTNew Delhi: In line with the proposal to manufacture and market Umeclidinium powder for inhalation 62.5mcg, the Subject Expert Committee (SEC)...
USFDA requests additional data on Sanofi Dupixent for treating smoker's lung Ruchika Sharma31 May 2024 3:16 PM ISTParis: Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) requested additional efficacy analyses on the efficacy...
Bisoprolol fails to improve outcomes in COPD patients at high risk of exacerbations: BICS trial Medha Baranwal28 May 2024 9:45 PM ISTUK: In a landmark advancement in managing chronic obstructive pulmonary disease (COPD), the findings of the BICS (Bisoprolol in COPD Study) randomized...
Dupilumab lowers exacerbations in COPD and type 2 inflammation and improves lung function: NEJM Dr. Kamal Kant Kohli25 May 2024 8:15 AM ISTChronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug-dupilumab-that showed rapid and sustained...
